|Basis of Allotment|
THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT AND DOES NOT CONSTITUTE AN INVITATION OR OFFER TO ACQUIRE. PURCHASE OR SUBSCRIBE FOR SECURITIES. NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, OUTSIDE INDIA.
THYROCARE TECHNOLOGIES LIMITED
Our Company was incorporated as Thyrocare Technologies Limited on January 28,2000 at Mumbai and received certificate of commencement of business on March 7,2000. It was incorporated as a public limited company under the companies act , 1956. For Details see rhe Section entitled "History and Certain Corporate Matters" on Page 151 of the prospectus dated May 3,2016 (the "Prospectus"}.
Registered Office; D/37-1, TTC Industrial Area, MlDC
Turbhe, Navi Mumbai 400 703;
Our Company has filed the prospectus dated May 3, 2016 with the registrar of the companies, Mumbai, Maharashtra and the Equity Shares are proposed to be listed on the BSE Limited ("BSE") and the National Stock Exchange of India limited ("NSE") and the trading will commence on may 9, 2016.
PROMOTERS OF OUR COMPANY : DR. A. VELUMANI AND MR. A. SUNDARARAJU
PUBLIC OFFER OF 10,744,708 EQUITY SHARES OF FACE VALUE OF RS 10 EACH (THE ''EQUITY SHARES') OF THYROCARE TECHNOLOGIES LIMITED (THE "COMPANY" OR THE "ISSUER") FOR CASH, AT A PRICE OF RS 446 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 436 PER EQUITY SHARE) THROUGH AN OFFER FOR SALE BY THE SELLING SHAREHOLDERS (AS DEFINED IN THE SECTION ENTITLED "DEFINITIONS AND ABBREVIATIONS" ON PAGE 1 OF THE PROSPECTUS) AGGREGATING TO RS 4,792.14 MILLION (THE "OFFER"). THE OFFER CONSTITUTES 20.00% OF OUR POST-OFFER PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
OFFER PRICE: RS 446 PER EQUITY SHARE OF FACE VALUE OF RS 10 EACH
Risks to Investors:
(i) The three Merchant Bankers associated with the Offer, have handled 18 public issues in the past three years out of which 5 issues closed below the issue price on listing date.
(ii) The average cost of acquisition per Equity Share for Promoters viz. Dr. A velumani is Rs 61.98 and Mr. A. Sundararaju is Rs 12.83 and for Selling Shareholders viz. Agalia Private Limited is Rs 110.67, A Velumani HUF is Rs 56.35, A. Sundararaju HUF is Rs 9.30 and Anand Velumani is Rs. 2.14. The Offer Price at upper end of the price band is Rs. 446.
BID/ OFFER PERIOD: OPENED ON: WEDNESDAY, APRIL 27, 2016;
In terms of Rule 19(2)(b)(ii) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR"), this is an Offer for at least such percentage of the post-Offer Equity Share capital of the Company that will be equivalent to at least Rs 4,000 million, calculated at the Offer Price. The Offer was made throug the Book Building Process in accordance with Regulation 26(1) of the SEBI Regulations wherein 50% of the Offer was allocated on a proportionate basis to Qualified Institutional Buyers ("QIB"),of which our Company and Selling Shareholders, in consultation with the BRLMs allocated upto 60% of the QIB Portion to Anchor Investors on a discretionary basis. One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Pnce. 5% of the QIB Portion (excluding the Anchor Investor Portion) was available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the QIB Portion was available for allocation on a proportionate basis to all QIB Bidders (other than Anchor Investors), including Mutual Funds, subject to valid Bids being received at or above the Offer Pnce Further, not less than 15% of the Offer was available for allocation on a proportionate basis to Non-Institutional Bidders and not less than 35% of the Offer was available for allocation to Retail Individual Bidders in accordance with the SEBI Regulations, subject to valid Bids being received at or above the Offer Price All potential Bidders, other than Anchor Investors, were required to mandatorily participate in this Offer through the ASBA Process providing details of their respective bank accounts which were blocked by the relevant SCSBs. Anchor Investors were not permitted to participate in the Offer through ASBA Process. For details, see the section entitled "Offer Procedure" on page 389 of the Prospectus.
The offer received 715,689 applications for 562,293,237 Equity Shares, (prior to technical rejections) resulting in 52.332 times subscription. The details of the applications, received in the Offer from various categories are as under: (before technical rejections):
*Excluding Multiple/duplicate bids
The Basis af Allotment was finalized in consultation with the Designated Stock Exchange, being the NSE, on May 5, 2016.
A. Allotment to Retail Individual Bidders (after technical rejections) (including ASBA Applications)
The Basis of Allotment to the Retail Individual Bidders, who have bid at the Cut-Off-Price or at the offer Price of Rs 446 per Equity Shares, was finalized in consultation with the NSE. This category has bean subscribed to the extent of 8.29 times. The total number of Equity Shares Allotted in Retail Individual Bidders category is 3,760,648 Equity Shares to 113,959 successful Retail individual Bidders. The category-wise details of the Basis of Allotmeni are as under
B. Allotment to Non-Institutional Bidders (After Technical Rejections)
The Basis of Allotment to the Non-institutional Bidders, who have bid at the Offer Price of Rs 446 per Equity Share was finalized in consultation with the NSE. This category has- been subscribed to the extent of 223.33 times. The total number of Equriy Shares Allotted in this category is 1,611,707 Equity Shares to 499 successful Non-lnstitutional Bidders. The category-wise details of the Basis of Allotment are as under: (SAMPLE)
C. Allotment to QIBs (excluding Anchor Investors)
Allotments QIBs (excluding Anchor Investors), who have Bid at the Offer Price of Rs 446 per Equity Share or above, has been done on a proportionate basis in consultation with the NSE. This category has been subscribed to the extent of 76.2122 times of the QIB Portion. As per the SEBI Regulations, Mutual Funds were Allotted 107,448 of the Equity Shares of the QIB Portion available i.e. 107,448 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e. 2,041,494 Equity Shares on a pnoporiionaie basis. The total number of Equity Shares Allotted in the QIB Portion is 2,148,942 Equity Shares which were allolted to 146 successful Bidders. The category-wise details of the Basis of Allotment are as under:
D. Allotment to Anchor Investors
The Company in consultation with the BRLMs have Allocated 3,223,411 Equity Shares to15 Anchor Investors through 29 Applications at the Anchor Investor Offer Price of Rs 446 per Equity Shares in accordance with the SEBI Regulations This represents 60% of the QIB ponion.
The IPO Committee of our company at its meeting held on may 5, 2016 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful Bidders. The instructions to the Self Certified Syndicate Banks for unlocking of funds, transfer to Public Offer account have been issued on May 5, 2016 and payment to non-Syndicate brokers have been issued on May 6, 2016. The Equity Shares Allotted to the successful Allottees have been uploaded an May 6, 2016 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned, Our company filed the Lisling application with NSE and BSE on May 6, 2016. The Company has received listing and trading approval from BSE and NSE and0 the trading will commence on May 9,2016.
All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus.
INVESTORS PLEASE NOTE
The details of the allotment made will be hosted on the website of the Registrar to the Offer, Link intime India Private Limited at www.linkintime.co.in
All Future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the first/sole Bidder, Bid cum Application Form number, Bidder DP ID, Client ID, PAN, date of submission of Bid cum Application Form, address, of the Bidder, number of Equity Shares applied for, the name and address of the Designated Intermediary where the Bid cum Applicaton Form was submitted by the Bidder, and a copy of the Acknowledgment Slip received from the Designated Intermediary at the address given below;
Link Intime India Private Limited
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF THYROCARE TECHNOLOGIES LlMITED.